Greg Everson - Concepedia

Author

Greg Everson

University of Colorado Denver

Also Known As

G Everson, G T Everson, G. Everson, G. T. Everson, G.T. Everson, Greg Everson, Greg T Everson, Greg T. Everson

Publications

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver University of Michigan University of California, San Francisco Northwestern University University of Pennsylvania

About

Greg Everson is an author at University of Colorado Denver specializing in medicine, hepatitis, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	841
2	Hepatology	5	5	569
3	Health Sciences	2	2	204
4	Diabetes	2	2	314
5	Epidemiology	2	2	51

Greg Everson

Publications

Citations

H-Index

Page 1

	Year	Citations
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease Michael Charlton, Gregory T. Everson, Steven L. Flamm, Gastroenterology	2015	795
Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Mark D. Stegall, Greg Everson, G Schröter, PubMed Solid Organ TransplantationSteroid-tapering PeriodHyperlipidemiaSurgeryFatty Liver Disease	1995	176
Outcomes of Living and Deceased Donor Liver Transplant Recipients With Hepatocellular Carcinoma: Results of the A2ALL Cohort Laura Kulik, Robert A. Fisher, Del R. Rodrigo, American Journal of Transplantation	2012	152
Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial Stanislas Pol, Reem Ghalib, Vinod K. Rustgi, The Lancet Infectious Diseases HepatologyHepatitis CViral HepatitisAntiviral TherapyHepatitis	2012	147
Prednisone Withdrawal Late After Adult Liver Transplantation Reduces Diabetes, Hypertension, and Hypercholesterolemia Without Causing Graft Loss Mark D. Stegall, Greg Everson, G Schröter, Hepatology Cyclosporine MonotherapyMg/d PrednisoneTransplantationHepatologyPrednisone Withdrawal	1997	138
Liver regeneration after living donor transplantation: Adult‐to‐adult living donor liver transplantation cohort study Kim M. Olthoff, Jean C. Emond, Tempie H. Shearon, Liver Transplantation	2014	101
Endoscopic Gallbladder Stent Placement for Treatment of Symptomatic Cholelithiasis in Patients with End-Stage Liver Disease Christine Schlenker, James F. Trotter, Raj J. Shah, The American Journal of Gastroenterology	2006	81
1356 QUADRUPLE THERAPY WITH BMS-790052, BMS-650032 AND PEG-IFN/RBV FOR 24 WEEKS RESULTS IN 100% SVR12 IN HCV GENOTYPE 1 NULL RESPONDERS Anna S. Lok, David Gardiner, Eric Lawitz, Journal of Hepatology Viral HepatitisImmunologyAntiviral TherapyHepatitisVirology	2011	65
O68 SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HCV WITH CIRRHOSIS AND PORTAL HYPERTENSION WITH AND WITHOUT DECOMPENSATION: EARLY VIROLOGIC RESPONSE AND SAFETY Nezam H. Afdhal, Greg Everson, José Luís Calleja, Journal of Hepatology HepatologyViral HepatitisLiver PhysiologyAntiviral TherapyHepatitis	2014	61
Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection. Roshan Shrestha, C McKinley, BM Bilir, PubMed ImmunologyPathologyImmunotherapyChronic Hepatitis CAutoimmune Liver Disease	1995	47

Page 1